Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C15H21NO2 |
| Molecular Weight | 247.3327 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NCC(O)COC1=C2C=CCC2=CC=C1
InChI
InChIKey=MPGBPFMOOXKQRX-UHFFFAOYSA-N
InChI=1S/C15H21NO2/c1-11(2)16-9-13(17)10-18-15-8-4-6-12-5-3-7-14(12)15/h3-4,6-8,11,13,16-17H,5,9-10H2,1-2H3
Indenolol hydrochloride is a nonselective beta-adrenoceptor antagonist. It is antihypertensive, antiarrhytmic, antianginal drug. It vasodilated forearm arterioles and this effect was antagonized by beta-blockade, thus demonstrating vascular intrinsic sympathomimetic activity. Indenol is able to inhibit an exercise-induced rise in systolic pressure. Indenolol would be able to decrease myocardial O2 consumption.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID70866817
Created by
admin on Mon Mar 31 18:14:05 GMT 2025 , Edited by admin on Mon Mar 31 18:14:05 GMT 2025
|
PRIMARY | |||
|
8GU15N96I8
Created by
admin on Mon Mar 31 18:14:05 GMT 2025 , Edited by admin on Mon Mar 31 18:14:05 GMT 2025
|
PRIMARY | |||
|
Indenolol
Created by
admin on Mon Mar 31 18:14:05 GMT 2025 , Edited by admin on Mon Mar 31 18:14:05 GMT 2025
|
PRIMARY | |||
|
71955
Created by
admin on Mon Mar 31 18:14:05 GMT 2025 , Edited by admin on Mon Mar 31 18:14:05 GMT 2025
|
PRIMARY | |||
|
106656-86-4
Created by
admin on Mon Mar 31 18:14:05 GMT 2025 , Edited by admin on Mon Mar 31 18:14:05 GMT 2025
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD
